Nursing care
Vancomycin: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Vancomycin is a glycopeptide antibiotic for serious gram-positive infections, including MRSA, and requires slow IV infusion, trough monitoring, and renal function checks. Infusion-related flushing is caused by rate, not allergy, and the trough level is drawn immediately before the next dose, not after infusion completes.
Why this drug and not another
Vancomycin is reached for when gram-positive infection is confirmed or suspected to be resistant to beta-lactams, most often MRSA, and in patients with a true penicillin allergy where a beta-lactam alternative is unsafe. It is not first-line for infections that respond to narrower-spectrum agents, because vancomycin carries nephrotoxicity risk and requires level monitoring that simpler antibiotics do not.
It is also used empirically in suspected sepsis or severe skin and soft tissue infection while cultures are pending, then continued or stopped based on sensitivities. Nurses should know why a patient is on vancomycin specifically — a MRSA-positive culture, a documented penicillin anaphylaxis, or unit protocol for undifferentiated sepsis — because that reason shapes how aggressively you monitor levels and how quickly you'd expect to see de-escalation once cultures return.
Administration and timing
Vancomycin is given by slow intermittent IV infusion, typically over at least 60 minutes per gram, with longer infusion times for larger doses — a 1.5 g dose over 90 minutes, 2 g over 120 minutes, following facility protocol. It is never given as an IV push. Central line administration is preferred for repeated dosing, but peripheral administration is common and requires attention to the IV site for signs of phlebitis.
Timing is dictated by renal function and target trough levels rather than a fixed interval for every patient — dosing intervals commonly range from every 8 to every 24 hours and are individualised. Because the drug is renally cleared, a patient with reduced kidney function needs a longer interval between doses even at the same dose amount, and pharmacy typically drives interval adjustment based on levels and creatinine clearance.
Monitoring parameters
Trough levels are the primary monitoring tool and are drawn immediately before the next scheduled dose, not after the infusion finishes — drawing it post-infusion or at a random time gives a falsely elevated result that can lead to unnecessary dose reduction. Coordinate with pharmacy and the lab so the sample is collected within roughly 30 minutes before the due dose, and hold the dose if the trough is pending and elevated, per order.
Serum creatinine and BUN should be trended throughout therapy to catch nephrotoxicity early, particularly in patients also receiving other nephrotoxic agents such as NSAIDs, aminoglycosides, or IV contrast. Some units also monitor complete blood counts with prolonged therapy, since vancomycin has been associated with neutropenia after extended courses. Urine output is a simple bedside indicator worth trending alongside labs.
Adverse effects to report
Nephrotoxicity is the adverse effect that changes management — rising creatinine, falling urine output, or an elevated trough should be reported promptly, as the dose or interval may need adjustment. Ototoxicity, presenting as tinnitus or hearing changes, is less common but is reported immediately because it can be irreversible.
Infusion-related reactions — flushing, pruritus, and a maculopapular rash typically affecting the face, neck, and upper torso — are caused by rapid infusion triggering histamine release, not by a true drug allergy. This is often called red man syndrome. The correct response is to slow or pause the infusion and treat symptomatically, not to label the patient as vancomycin-allergic on the chart. Distinguishing this from anaphylaxis matters: true allergic reactions include hypotension, wheeze, or angioedema, and red man syndrome does not, though severe cases can cause hypotension from histamine release alone if the rate isn't corrected.
Contraindications and cautions
Vancomycin requires caution rather than absolute avoidance in most patients, but pre-existing renal impairment demands closer monitoring and likely dose or interval adjustment from the start of therapy, not just after a trough comes back high. Concurrent use with other nephrotoxic or ototoxic drugs increases risk and should prompt closer lab surveillance.
A documented true allergy to vancomycin itself, as opposed to infusion-rate-related flushing, is a genuine contraindication and should be clearly distinguished in the chart from red man syndrome so future clinicians don't withhold a needed antibiotic unnecessarily. In neonates and older adults, altered renal clearance and volume of distribution make dosing and monitoring intervals tighter, and pharmacy involvement in dosing is standard.
Teaching points the exam tests
NCLEX questions on vancomycin typically test whether you recognise red man syndrome as a rate-related infusion reaction rather than a true allergy, with the correct nursing action being to slow the infusion rather than stop it outright and reclassify the patient as allergic. Expect a question stem describing facial flushing during infusion and asking for the priority action — slowing the rate is the answer the exam wants, alongside continued monitoring.
Also expect questions on trough timing: a stem describing a trough drawn after the infusion, or at a time unrelated to the next dose, is testing whether you know the sample is invalid and should be drawn just before the next dose. Questions may also present a rising creatinine during vancomycin therapy and ask for the priority nursing action, where notifying the provider and anticipating a hold or dose adjustment is prioritised over administering the next dose as scheduled.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
What is red man syndrome and is it an allergy?
Red man syndrome is flushing, pruritus, and rash from histamine release triggered by rapid vancomycin infusion — it is a rate-related reaction, not an IgE-mediated allergy. Slowing the infusion rate and premedicating with an antihistamine on subsequent doses usually allows the drug to be continued safely.
When should a vancomycin trough be drawn?
Immediately before the next scheduled dose, generally within about 30 minutes prior. Drawing it at any other time, including right after the infusion ends, gives an inaccurate result and can lead to an incorrect dose adjustment.
Why is vancomycin never given as an IV push?
Rapid administration dramatically increases the risk and severity of histamine-mediated infusion reactions and can cause profound hypotension. It must be diluted and infused slowly over the time specified for the dose given.
What labs should be monitored during vancomycin therapy?
Trough levels, serum creatinine, and BUN throughout the course, with urine output trended at the bedside. Extended therapy warrants periodic complete blood counts because prolonged use has been linked to neutropenia.
How does the nurse tell red man syndrome apart from anaphylaxis?
Red man syndrome causes flushing, pruritus, and rash typically on the face, neck, and upper body without respiratory or significant cardiovascular compromise. True anaphylaxis includes wheeze, angioedema, or hypotension unrelated to infusion rate, and requires stopping the drug and treating as an allergic emergency rather than simply slowing the rate.
More on pharmacology
Guides on this